Home / Entertainment / Hollywood News / Article / Jasveen Sangha pleads guilty in Matthew Perry overdose case

Jasveen Sangha pleads guilty in Matthew Perry overdose case

Sangha has been in federal custody since August 2024 and was scheduled to stand trial in Los Angeles on September 23. Plasencia took a plea deal in June in which he admitted to distributing ketamine to Perry

Listen to this article :
Matthew Perry. Pic/AFP

Matthew Perry. Pic/AFP

Jasveen Sangha, also known as the "Ketamine Queen", has agreed to plead guilty in connection with the overdose death of Hollywood actor Matthew Perry, reported Variety. Sangha will plead guilty to five counts, including distributing ketamine that resulted in a death and maintaining a "drug-involved" premises. She faces at least 11 years in prison during her sentence, which is anticipated to take place in the coming months.

Defendants in Matthew Perry case

She is the last of five defendants to plead guilty in connection with the actor`s death. Perry, known for his role in the television series `Friends`, was found dead at his residence in October 2023. Sangha has been in federal custody since August 2024 and was scheduled to stand trial in Los Angeles on September 23. Plasencia took a plea deal in June in which he admitted to distributing ketamine without a legitimate medical purpose to the `Friends` star, who died of an overdose in October 2023. In exchange, prosecutors dropped charges of falsifying medical records and additional counts of distribution, Variety reported. Three other defendants are Erik Fleming, Kenneth Iwamasa and Mark Chavez, previously agreed to plead guilty to conspiracy to supply ketamine.

Late actor Matthew Perry`s doctor, Salvador Plasencia, pleaded guilty to giving the Friends star ketamine before his tragic death. During a hearing in Los Angeles, the doctor admitted to supplying four counts of illegal distribution of the drug, which is used as a prescription anaesthetic.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement
;